IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


7,312 results7,312 results
16
of
366
Deal Highlights
0 results0 results
Deal Name Deal Date Firm Name Jurisdiction Deal Type Lawyer Names Client Names Client Role
There are no results
By Firm
0 results0 results
Firm Name Jurisdiction Total Deals Deals (Last 12 Months)
There are no results
Additions from Clifford Chance, Mayer Brown, Akin and Freshfields headlined a week that also included an M&A hire for Paul Weiss and Cleary’s hire of a PE-focused debt finance partner
M&A
Clemens York discusses how expanding EU regulatory regimes are reshaping transaction execution, from data preparation and deal documentation to cross-practice matter staffing
As AI changes what sponsors buy, advisers must sharpen their focus on valuation, data rights and resilience
Paul Hastings’ latest finance hires from Cahill and Ropes & Gray stood out in a week that also saw Akin and Charles Russell Speechlys add corporate partners
M&A
The firm believes its sector focus will help it stand out in a competitive market for M&A advisers, its global managing partner tells IFLR
We round up this week’s top moves in the finance, corporate, M&A and PE practices in the UK, France, the US and Germany
As Islamic capital markets broaden beyond their traditional centres, fresh demands around standardisation, disclosure and product design are coming into focus
As Italy updates its securitisation framework, corporates gain more flexible financing tools
Sponsored

Sponsored

  • IFLR1000
    Sponsored by Bär & Karrer
    Nxera Pharma Co. Ltd, listed on the Tokio Stock Exchange, has entered into an exclusive licensing agreement with Santhera Pharmaceuticals under which Nxera will commercialize the drug AGAMREE® in Japan, South Korea, Australia and New Zealand. Concurrently, Nxera invests in SIX-listed Santhera Pharmaceuticals Holding AG.
  • IFLR1000
    Sponsored by Bär & Karrer
    In connection with a carve-out process, the Ortlinghaus Group sold its EM+H Division, which encompasses among others the production and sale of electromagnetic brakes and clutches as well as pneumatic toothed clutches and other trade goods to Stüwe Switzerland AG, a group company of Stüwe GmbH & Co. KG.
  • IFLR1000
    Sponsored by Zepos & Yannopoulos
    Zepos & Yannopoulos continues its longstanding presence and active involvement in landmark transactions in the food & beverage retail sector in Greece. We advised ANEDIK Kritikos on the sale of 100% of ANEDIK Kritikos S.A. to Diamantis Masoutis S.A., paving the way for the creation of a new national retail group, subject to approval by the Hellenic Competition Commission.